|
Issue |
Title |
|
Vol 13, No 1 (2025) |
Antipsychotic-Induced Parkinsonism: A Risk Assessment Scale and Personalised Diagnosis Algorithm |
Abstract
PDF (Rus)
|
N. A. Shnayder, E. E. Vaiman, R. F. Nasyrova |
|
Vol 13, No 1 (2025) |
Medication Errors Associated with the Use of Levofloxacin: An Analysis of the National Database of Spontaneous Reports |
Abstract
PDF (Rus)
|
I. L. Asetskaya, S. K. Zyryanov, K. I. Samsonova, O. I. Butranova, E. N. Terekhina, V. A. Polivanov |
|
Vol 13, No 1 (2025) |
Diagnosis and Prognostic Assessment of Drug-Induced Liver Injury: What Are the Outpatient Options? (Review) |
Abstract
PDF (Rus)
|
E. V. Gantsgorn, A. V. Bozhko, S. V. Yarchenko |
|
Vol 13, No 1 (2025) |
Relevant Species Selection for Preclinical Safety Studies of Medicines: A Review |
Abstract
PDF (Rus)
|
G. N. Engalycheva, R. D. Syubaev |
|
Vol 13, No 1 (2025) |
Safety of the New Russian Anti-smallpox Medicinal Product NIOCH-14: Open, Randomised Phase I Clinical Trial Results |
Abstract
PDF (Rus)
|
L. N. Shishkina, M. P. Bogryantseva, N. I. Bormotov, S. V. Usova, M. O. Skarnovich, O. Yu. Mazurkov, E. S. Bashkina, N. S. Kutserubova, S. G. Udalyeva, A. A. Sergeev, A. P. Agafonov |
|
Vol 13, No 1 (2025) |
Effects of Food on the Bioavailability of Medicinal Products in Bioequivalence Studies: A Comparative Analysis of Regulatory Documents |
Abstract
PDF (Rus)
|
N. N. Eremenko |
|
Vol 13, No 1 (2025) |
Efficacy and Safety of Herbal Medicinal Products: Registration Requirements in the EAEU and Other Regions of the World (Review) |
Abstract
PDF (Rus)
|
N. G. Olenina |
|
Vol 13, No 1 (2025) |
Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review) |
Abstract
PDF (Rus)
|
I. A. Mazerkina |
|
Vol 13, No 1 (2025) |
Improving the Pharmacovigilance System in Medical Organisations as an Opportunity to Enhance the Quality of Pharmacotherapy |
Abstract
PDF (Rus)
|
M. V. Zhuravleva, S. Yu. Serebrova, E. V. Kuznetsova, T. R. Kameneva, A. V. Vlasova, A. B. Prokofiev, E. Yu. Demchenkova |
|
1 - 9 of 9 Items |
|